コンテンツへスキップ
Merck

B0300000

バルビタール

European Pharmacopoeia (EP) Reference Standard

別名:

5,5-ジエチル-2,4,6(1H,3H,5H)-ピリミジントリオン, 5,5-ジエチルバルビツール酸, バルビトーン, ベロナール

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
C8H12N2O3
CAS番号:
分子量:
184.19
Beilstein:
163999
MDL番号:
UNSPSCコード:
41116107
PubChem Substance ID:
NACRES:
NA.24

グレード

pharmaceutical primary standard

APIファミリー

barbital

メーカー/製品名

EDQM

薬剤管理

USDEA Schedule IV; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

アプリケーション

pharmaceutical (small molecule)

フォーマット

neat

保管温度

2-8°C

SMILES記法

CCC1(CC)C(=O)NC(=O)NC1=O

InChI

1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)

InChI Key

FTOAOBMCPZCFFF-UHFFFAOYSA-N

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Barbital EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生物化学的/生理学的作用

鎮静剤/催眠剤

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

ピクトグラム

Exclamation mark

シグナルワード

Warning

危険有害性情報

注意書き

危険有害性の分類

Acute Tox. 4 Oral

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable


Choose from one of the most recent versions:

試験成績書(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Carolina Salcedo-Rivillas et al.
Clinical and vaccine immunology : CVI, 21(7), 972-981 (2014-05-09)
Pneumococcal surface protein A (PspA) is a candidate antigen for the composition of protein-based vaccines against Streptococcus pneumoniae. While searching for efficient adjuvants for PspA-based vaccines, our group has described the potential of combining PspA with the whole-cell pertussis vaccine
Megan Dodd et al.
The journal of gene medicine, 16(5-6), 131-142 (2014-06-21)
Hemophilia B patients are subject to frequent and spontaneous bleeding caused by a deficiency of clotting factor IX (FIX). Mesenchymal stromal cells (MSCs) have been used in cellular therapies as a result of their immunomodulatory properties, the ability to home
Kalana Maduwage et al.
PLoS neglected tropical diseases, 8(12), e3304-e3304 (2014-12-19)
Venom recurrence or persistence in the circulation after antivenom treatment has been documented many times in viper envenoming. However, it has not been associated with clinical recurrence for many snakes, including Russell's viper (Daboia spp.). We compare the recovery of
Juergen Patzke et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 25(8), 860-870 (2014-09-06)
The functional activity of von Willebrand factor (VWF) is most frequently measured by using the ristocetin cofactor assay (VWF:RCo). However, the method's drawbacks include unsatisfactory precision, sensitivity and availability of automated system applications. We have developed an alternative assay (INNOVANCE
Sophie Stukas et al.
Journal of lipid research, 55(8), 1721-1729 (2014-06-22)
A key step in plasma HDL maturation from discoidal to spherical particles is the esterification of cholesterol to cholesteryl ester, which is catalyzed by LCAT. HDL-like lipoproteins in cerebrospinal fluid (CSF) are also spherical, whereas nascent lipoprotein particles secreted from

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)